YOSHITAKAISAKA SuitaJapan

Wcn26 Post edited Speaker Card

29 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 3 AkiraNishiyama Chair nishiyama.akira@kagawa-u.ac.jpJapan MarikoMiyazaki Chair mamiyaza@venus.dti.ne.jpJapan Urinary Uric Acid Excretion and Kidney Outcome YOSHITAKAISAKA Speaker isaka@kid.med.osaka-u.ac.jpJapan Uric Acid and Progression of DKD JunWada Speaker junwada@okayama-u.ac.jpJapan 304
5 p.m. 6 p.m.	Industry Symposium 30 YOSHITAKAISAKA Chair isaka@kid.med.osaka-u.ac.jpJapan Transformative Insights from the DAPA-CKD Trial: Lessons for the Future of Kidney Care NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 501 - 502

30 March 2026

Time

Session

12:50 p.m.

1:50 p.m.

Industry Symposium 46

YOSHITAKAISAKA Chair isaka@kid.med.osaka-u.ac.jpJapan

Pathophysiology of C3G and Importance of Early Diagnosis

YOSHITAKAISAKA Speaker isaka@kid.med.osaka-u.ac.jpJapan
Case studies: Different Patient Profiles

CarlaNester Speaker carla-nester@uiowa.eduUnited States

DavidKavanagh Speaker David.Kavanagh@newcastle.ac.ukUnited Kingdom

Paul Brinkkötter Speaker paul.brinkkoetter@uk-koeln.deGermany
Guidelines and Redefining Standard of Care
Audience Q&A

503